Media Summary: In this webinar, Brett Drummond (co-founder of Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled ... Recently, our co-founder and chief science communicator, Brett Drummond, was invited to participate in

Mstranslate Ectrims 2022 Multiple Sclerosis - Detailed Analysis & Overview

In this webinar, Brett Drummond (co-founder of Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled ... Recently, our co-founder and chief science communicator, Brett Drummond, was invited to participate in In this video, Brett Drummond (Co-Founder, Dr. Brigit de Jong from Amsterdam UMC and Professor Alan Thompson from Queens Square Institute of Neurology in London ... Is it possible to predict whether individuals newly diagnosed with

Photo Gallery

MStranslate & ECTRIMS 2022: Multiple Sclerosis Research Update with Brett Drummond
ECTRIMS 2022: Research Insights from Day One
ECTRIMS 2022: Research Insights from Day Three
ECTRIMS 2022: Research Insights from Day Two
ECTRIMS 2022 For People with MS: Part 1
Multiple Sclerosis Research: ACTRIMS 2022 Update with Dr Barry Singer
Exciting ECTRIMS 2022 Announcement
ECTRIMS 2022: Remyelination Research Insights - Dr Travis Stiles & A/Prof Alban Gaultier
Multiple Sclerosis Limited Podcast: ECTRIMS 2021 Research Insights
Multiple Sclerosis & Remyelination Research
ECTRIMS 2022 For People with MS: Part 2
The ECTRIMS 2022 Event for People with MS
Sponsored
Sponsored
View Detailed Profile
MStranslate & ECTRIMS 2022: Multiple Sclerosis Research Update with Brett Drummond

MStranslate & ECTRIMS 2022: Multiple Sclerosis Research Update with Brett Drummond

In this webinar, Brett Drummond (co-founder of

ECTRIMS 2022: Research Insights from Day One

ECTRIMS 2022: Research Insights from Day One

Brett Drummond (Co-founder,

Sponsored
ECTRIMS 2022: Research Insights from Day Three

ECTRIMS 2022: Research Insights from Day Three

At the conclusion of

ECTRIMS 2022: Research Insights from Day Two

ECTRIMS 2022: Research Insights from Day Two

Brett Drummond (Co-founder,

ECTRIMS 2022 For People with MS: Part 1

ECTRIMS 2022 For People with MS: Part 1

Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled ...

Sponsored
Multiple Sclerosis Research: ACTRIMS 2022 Update with Dr Barry Singer

Multiple Sclerosis Research: ACTRIMS 2022 Update with Dr Barry Singer

In this video, Brett Drummond (

Exciting ECTRIMS 2022 Announcement

Exciting ECTRIMS 2022 Announcement

The

ECTRIMS 2022: Remyelination Research Insights - Dr Travis Stiles & A/Prof Alban Gaultier

ECTRIMS 2022: Remyelination Research Insights - Dr Travis Stiles & A/Prof Alban Gaultier

In this

Multiple Sclerosis Limited Podcast: ECTRIMS 2021 Research Insights

Multiple Sclerosis Limited Podcast: ECTRIMS 2021 Research Insights

Recently, our co-founder and chief science communicator, Brett Drummond, was invited to participate in

Multiple Sclerosis & Remyelination Research

Multiple Sclerosis & Remyelination Research

In this video, Brett Drummond (Co-Founder,

ECTRIMS 2022 For People with MS: Part 2

ECTRIMS 2022 For People with MS: Part 2

Dr. Brigit de Jong from Amsterdam UMC and Professor Alan Thompson from Queens Square Institute of Neurology in London ...

The ECTRIMS 2022 Event for People with MS

The ECTRIMS 2022 Event for People with MS

... Research in

ECTRIMS 2019: Predictors of Aggressive Multiple Sclerosis

ECTRIMS 2019: Predictors of Aggressive Multiple Sclerosis

Is it possible to predict whether individuals newly diagnosed with